AVRICORE HEALTH INC (AVCR.CA) Fundamental Analysis & Valuation
TSX-V:AVCR • CA0545211090
Current stock price
0.07 CAD
+0.01 (+7.69%)
Last:
This AVCR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AVCR.CA Profitability Analysis
1.1 Basic Checks
- In the past year AVCR has reported negative net income.
- In the past year AVCR has reported a negative cash flow from operations.
- In the past 5 years AVCR always reported negative net income.
- In multiple years AVCR reported negative operating cash flow during the last 5 years.
1.2 Ratios
- AVCR's Return On Assets of -122.49% is on the low side compared to the rest of the industry. AVCR is outperformed by 60.00% of its industry peers.
- The Return On Equity of AVCR (-125.89%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -122.49% | ||
| ROE | -125.89% | ||
| ROIC | N/A |
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 43.48%, AVCR is in line with its industry, outperforming 60.00% of the companies in the same industry.
- In the last couple of years the Gross Margin of AVCR has declined.
- AVCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
2. AVCR.CA Health Analysis
2.1 Basic Checks
- AVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- AVCR has more shares outstanding than it did 1 year ago.
- AVCR has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for AVCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 91.01 indicates that AVCR is not in any danger for bankruptcy at the moment.
- AVCR has a Altman-Z score of 91.01. This is amongst the best in the industry. AVCR outperforms 100.00% of its industry peers.
- There is no outstanding debt for AVCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 91.01 |
ROIC/WACCN/A
WACC9.01%
2.3 Liquidity
- AVCR has a Current Ratio of 17.92. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 17.92, AVCR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- AVCR has a Quick Ratio of 17.81. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
- AVCR's Quick ratio of 17.81 is amongst the best of the industry. AVCR outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 17.92 | ||
| Quick Ratio | 17.81 |
3. AVCR.CA Growth Analysis
3.1 Past
- The earnings per share for AVCR have decreased strongly by -1820.00% in the last year.
- AVCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -59.28%.
- Measured over the past years, AVCR shows a very strong growth in Revenue. The Revenue has been growing by 170.57% on average per year.
EPS 1Y (TTM)-1820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
Revenue 1Y (TTM)-59.28%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-96.85%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. AVCR.CA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AVCR. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. AVCR.CA Dividend Analysis
5.1 Amount
- AVCR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AVCR.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:AVCR (4/30/2026, 7:00:00 PM)
0.07
+0.01 (+7.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Industry Strength9.45
Industry Growth45.52
Earnings (Last)12-01 2025-12-01
Earnings (Next)05-06 2026-05-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.94%
Ins Owner ChangeN/A
Market Cap7.09M
Revenue(TTM)1.92M
Net Income(TTM)-1.63M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.69 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.48 | ||
| P/tB | 5.8 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -122.49% | ||
| ROE | -125.89% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.48% | ||
| FCFM | N/A |
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
F-Score4
Asset Turnover1.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 47.74% | ||
| Cap/Sales | 6.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 17.92 | ||
| Quick Ratio | 17.81 | ||
| Altman-Z | 91.01 |
F-Score4
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)316.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)34.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-59.28%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-96.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-890.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-137.82%
OCF growth 3YN/A
OCF growth 5YN/A
AVRICORE HEALTH INC / AVCR.CA Fundamental Analysis FAQ
What is the fundamental rating for AVCR stock?
ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA.
Can you provide the valuation status for AVRICORE HEALTH INC?
ChartMill assigns a valuation rating of 0 / 10 to AVRICORE HEALTH INC (AVCR.CA). This can be considered as Overvalued.
What is the profitability of AVCR stock?
AVRICORE HEALTH INC (AVCR.CA) has a profitability rating of 1 / 10.